Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
XORTX Therapeutics Inc. (XRTX) had Stock-Based Compensation of $0.01M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-0.70M |
|
-- |
|
-- |
|
$0.96M |
|
$-0.96M |
|
$0.26M |
|
$-0.70M |
|
$-0.70M |
|
$-0.70M |
|
$-0.70M |
|
$-0.70M |
|
$-0.70M |
|
$-0.96M |
|
$-0.94M |
|
3.74M |
|
3.74M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$2.10M |
|
$0.02M |
|
$1.40M |
|
$3.50M |
|
$0.76M |
|
-- |
|
-- |
|
$0.76M |
|
$2.74M |
|
$2.56M |
|
$2.74M |
|
3.79M |
|
| Cash Flow Statement Financials | |
$-0.64M |
|
$-0.00M |
|
$0.07M |
|
$2.47M |
|
$1.90M |
|
$-0.58M |
|
|
Stock-Based Compensation |
$0.01M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.78 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-25.49% |
|
-27.28% |
|
-19.97% |
|
-25.49% |
|
$0.72 |
|
$-0.17 |
|
$-0.17 |
|